PERSONAL DETAIL


ASSOCIATE PROF. DR. IVY CHUNG

Department of Pharmacology
Faculty of Medicine
 
  7967 3199
  7967 4791
  ivychung@um.edu.my
 Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, W.Persekutuan Kuala Lumpur, Malaysia
 
ResearcherID Link
  http://www.researcherid.com/rid/C-3804-2012


BIBLIOMETRIC DATA


 Total Articles in Publication List  22
 Articles With Citation Data  20
 Sum of the Times Cited   697
 Average Citations per Article   34.85
 h-index   15
 Co-authors   Collaboration Network
 This information is generated from http://researcherid.com

ACADEMIC QUALIFICATION
(Qualification), (Institution).



PROFESSIONAL
(Organisation), (Role), (Year), (Level).


  • Malaysian Association for the Study of Obesity, Active Member,   to  , (National)
  • Association for Cancer Research (AACR), Active Member, 2005 to 2017, (International)
  • Journal of Health and Translational Medicine (JUMMEC), Editorial Member, 2013 to 2017, (National)
  • Laboratory Animal Science Association of Malaysia, Active Member, 2013 to 2013, (National)
  • Malaysian Association of Pharmacology and Physiology, Committee Member, 2014 to 2015, (National)

ADMINISTRATIVE DUTIES
(Role), (Level), (Start date),(End Date).


  • Deputy Dean of Research Cluster, Kluster Penyelidikan Health & Well-Being, Deputy Vice Chancellor(Research & Innovation), 01/12/2018 to 30/11/2020
  • Deputy Dean, Wellness Research Kluster, Deputy Vice Chancellor(Research & Innovation), 01/07/2018 to 30/09/2018
  • Deputy Dean, Wellness Research Kluster, Deputy Vice Chancellor(Research & Innovation), 01/01/2018 to 30/06/2018
  • Deputy Dean, Wellness Research Kluster, Deputy Vice Chancellor(Research & Innovation), 03/01/2017 to 31/12/2017
  • Deputy Dean, Wellness Research Kluster, Deputy Vice Chancellor(Research & Innovation), 10/08/2015 to 31/12/2016
  • Committee, National, 12/06/2018 to 11/06/2020 (MyKidney Program, JPT, MOE)
  • Committee, Program CEO@Faculty 2.0 cycle 2, Ministry of Education, National, 15/03/2018 to 14/03/2020
  • Committee, CEO@Faculty 2.0 cycle 2, MOE Interview session, National, 15/03/2018 to 25/04/2018
  • Committee, CEO@Faculty Program 2.0 cycle 2 Bootcamp, MOE, National, 15/03/2018 to 06/05/2018
  • Ahli Jawatankuasa Fasiliti Gunasama Penyelidikan dan Perkhidmatan (JFGPP), Fakulti Perubatan, University Malaya, 03/01/2017 to 31/12/2018
  • Penyelaras Penyelidikan (Antarabangsa), University Malaya, 01/07/2016 to 31/12/2018 (NA)
  • Jawatankuasa Penasihat Accelerator Diagnostik Sains Hayat Bangunan I2U UM, University Malaya, 26/02/2016 to 25/02/2018 (NA)
  • Technical Committee Member for Bioinspire Program, University Malaya, 24/02/2016 to 31/12/2017 (NA)
  • AJK Penilai Pengkomersilan Universiti Malaya, University Malaya, 04/01/2016 to 03/01/2018 (NA)
  • Technical & Logistic Committee, UM Research Carnival 2015, University Malaya, 04/09/2015 to 10/10/2015
  • AJK Penilaian bagi Permohonan Geran Penyelidikan, IPPP, University Malaya, 04/03/2015 to 31/12/2016 (NA)
  • Coordinator for Biomedical Sciences undergraduate program, MBEB2105 and MDEB4101 , Faculty, 27/01/2014 to 31/01/2015
  • Ahli Jawatankuasa Makmal Gunasama Fakulti Perubatan, Faculty, 24/01/2014 to 31/12/2016 (NA)
  • Coordinator for Translational Core Laboratory, Faculty, 20/01/2014 to 31/12/2018 (NA)
  • Ahli Lembaga Penasihat Advanced Imaging Unit, Faculty, 02/12/2013 to 31/12/2016 (N/A)
  • Ahli Jawatankuasa "Research Strategic Planning for Faculty of Medicine", Faculty, 01/06/2013 to 31/05/2014
  • Ahli Jawatankuasa Penilaian Sebutharga untuk Jabatan Surgeri - Digital slide scanner, Faculty, 22/02/2013
  • Ahli Jawatankuasa Penilaian Sebutharga untuk Jabatan Farmakologi, Faculty, 10/10/2012
  • Ahli Jawatankuasa Penilaian Sebutharga untuk Non-alcoholic fatty liver disease, Faculty, 26/09/2012
  • Academic Advisor for Phase 2 MBBS students, Faculty, 01/08/2012 to 01/08/2013
  • Ahli Jawatankuasa Penilaian Sebut Harga untuk Projek Non-Alcoholic Fatty Liver Disease, Faculty, 02/11/2011
  • Program Coordinator (Penyelaras Program) for Jawatankuasa Ijazah Tinggi Fakulti Perubatan (JKITFP), Faculty, 14/08/2011 to 31/12/2014
  • Coordinator for Department of Pharmacology Journal Club, Faculty, 21/07/2011 to 31/12/2013

AREAS OF EXPERTISE
(Area).


  • Molecular Pharmacology (Oncology, Molecular mechanism, Therapeutics)


RECENT SELECTED PUBLICATIONS
(Publication).


Chapter in Book

2014
  • Chung, I. Tumor fibroblasts: pivotal players in drug resistance. In: Morais, C. ed. Advances in drug resistance research, Nova Science Publishers, N.Y., USA. (In Press) 
Article in Academic Journals

2018
  • Cheong JE, Zaffagni M, Chung I, Xu Y, Wang Y, Jernigan FE, Zetter BR and Sun L. (2018) Synthesis and anticancer activity of novel water soluble benzimidazole carbamates. European Journal of Medicinal Chemistry, 144:372-385. (ISI-Indexed)

2017
  • Yap CV, Subramaniam KS, Khor SW and Chung I (2018). Annonacin exerts antitumor activity through induction of apoptosis and extracellular signal-regulated kinase inhibition. Pharmacognosy Research, 9(4):378-83. (ISI-Indexed)
  • Wu, YS, Chung I, Wong WF, Masamune A, Sim MS, and Looi CY (2016). Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Biochimica et Biophysica Act, 1861, 296-306. (Impact factor: 4.702) (ISI-Indexed)

2016
  • Subramaniam KS, Omar IS, Kwong SC, Mohamed Z, Woo YL, Mat Adenan NA, Chung I. 2016. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. American Journal of Cancer Research. (ISI-Indexed)
  • Wu YS, Looi CY, Subramaniam KS, Masamune A and Chung I. 2015. Stellate cells secretion induces pancreatic cancer cell proliferation via Nrf2-mediated metabolic reprogramming and ROS detoxification. Oncotarget (ISI-Indexed)

2015
  • Varatharajan V, Saravanan J, Chung I, Abdullah NA. 2015. Overview of Diabetic Nephropathy. PTB Reports 1(3): 104-110. (ISI-Indexed)
  • Varatharajan R, Lim LX, Tan K, Tay CS, Teoh YL, Akhtar SS, Rupeshkumar M, Chung I, Abdullah NA, Banik U, Dhanaraj SA, Balakumar P. 2015. Effect of Edaravone in diabetes mellitus-induced nephropathy in rats. Korean Journal of Physiology and Pharmacology (ISI-Indexed)

2014
  • Banyard J, Chung I, Migliozzi M, Phan DT, Wilson AM, Zetter BR and Bielenberg D. 2014. Identification of genes regulating micration and invasion using a new model of metastatic prostate cancer. BMC Cancer 14 (1):387. (ISI-Indexed)
  • Lee ML, Fung SY, Chung I, Pailoor J, Cheah SH and Tan NH. King cobra (Ophiophagus Hannah) venom L-amino acid oxidase induces apoptosis in PC-3 cells and suppresses PC-3 solid tumor growth in a tumor xenograft mouse model.2014.International Journal of Medical Sciences 11:593-601. (ISI-Indexed)

2013
  • Zhang Y, Yan W, Collins MA, Bednar F, Rakshit S, Zetter BR, Stanger BZ, Chung I, Rhim AD and di Magliano MP. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Research 73(20):6359-74 (2013) (ISI-Indexed)
  • 4.Lee ML, Chung I, Fung SY, Kanthimathi MS and Tan NH. Anti-proliferative activity of king cobra (Ophiophagus hannah) venom L-amino acid oxidase. Basic & Clinical Pharmacology & Toxicology. doi: 10.1111/bcpt.12155 (2013). (ISI-Indexed)
  • 1.Banyard J, Chung I, Wilson A, Vetter G, Le Bechec A, Bielenberg D and Zetter BR. Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model. Scientific Reports 3:3151 (2013) (ISI-Indexed)
  • Subramaniam KS, Tham ST, Zahurin M, Woo YL, Noor Azmi MA and Chung I. Cancer-associated fibroblasts promote proliferation of endometrial cancer cells. Plos One (2013) (revision). 
  • Rajavel V, Sattar MZ, Chung I, Abdulla MA, Kassim NM and Abdullah NA. Antioxidant and pro-oxidant effects of oil palm (Elaeis guineensis) leaves extract in experimental diabetic nephropathy: a duration-dependent outcome. BMC Complementary and Alternative Medicine 13(1):242 (2013). (ISI-Indexed)
  • Kavita S. Subramaniam, Seng Tian Tham, Zahurin Mohamed, Yin Ling Woo, Noor Azmi Mat Adenan, Ivy Chung. Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells. PLOS ONE 8(7):E68923 JULY 2013 . Impact Factor 3.534 DOI: 10.1371/journal.pone.0068923 (ISI-Indexed)
  • Chung I, Godoy AS*, Montecinos V, Buttyan R, Johnson CS and Smith GA. 2013. Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate. American Journal of Physiology �C Endocrinology & Metabolism (accepted). (ISI-Indexed)

2012
  • Rachelle R. Olsen, Ivy Chung and Bruce R. Zetter.2012. Knockdown of antizyme inhibitor decreases prostate tumor growth in vivo. Amino Acids. (ISI-Indexed)

2011
  • Chung I, Holleman A*, Olsen RR, Kwak B and Zetter BR. 2011. miR-135a as potential biomarker for development of taxane resistance in human cancer. Oncogene 30(43):4386-4398 (*shared first authorship) (ISI-Indexed)
  • Rummel N, Chung I and Shaikh Badar. 2011. Determination of albendazole, fenbendazole, and their metabolites in mice plasma by high performance liquid chromatography. Journal of Liquid Chromatography & Related Technologies 34(18):2211-2223. (ISI-Indexed)
  • Spivey KA, Chung I, Banyard J, Adini I, Feldman HA and Zetter BR. 2011. A role of collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis. Oncogene Oct 3 (Epub ahead of print) (ISI-Indexed)

2010
  • Patel N, Chatterjee SK, Vrbanac V, Chung I, Mu CJ, Olsen RR, Waghorne C and Zetter BR. 2010. Rescue of paclitaxel sensitivity by repression of prohibitin 1 in drug-resistant cancer cells. Proceedings of the National Academy of Sciences 107(6):2503-2508 (ISI-Indexed)
  • Johnson CS, Chung I and Trump DL. 2010. Epigenetic silencing of CYP24 in the tumor microenvironment. Journal of Steroid Biochemistry and Molecular Biology 121(1-2):338-42. (ISI-Indexed)

2007
  • Chung I, Yu WD, Karpf AR, Flynn G, Bernardi RJ, Modzelewski RA, Johnson CS and Trump DL. 2007. Anti-proliferative effects of calcitriol on endothelial cells derived from two different microenvironments. J. Steroid Biochemistry and Molecular Biology 103(3-5):768-70. (ISI-Indexed)
  • Adachi T, Nakagawa H, Chung I, Hagiya Y, Hoshijima K, Noguchi N, Kuo MT and Ishikawa T. 2007. Nrf2-dependent and ¿independent nduction of ABC transporters ABCC1, ABCC2, and ABCG2 in HepG2 cells under oxidative stress. Journal of Experimental Therapeutics and Oncology 6(4):335-348. (SCOPUS-Indexed)

2006
  • Flynn G, Chung I, Yu WD, Romano M, Modzelewski RA, Johnson CS and Trump DL. 2006. Calcitriol (1,25-dihydroxycholecalciferol) selectively inhibits proliferation of freshly isolated tumor-derived endothelial cells and induces apoptosis. Oncology 70(6):447-457. (ISI-Indexed)
  • Chung I, Wong MK, Flynn G, Yu WD, Johnson CS and Trump DL. 2006. Differential anti-proliferative effects of calcitriol on tumor-derived and Matrigel-derived endothelial cells. Cancer Research 66: 8565-8573. (ISI-Indexed)

AREAS OF RESEARCH
(Project title), (Role), (From)-(Until), (Level), (Source).


  • Longhouse And Communal Living Promoting Healthy Ageing In Bario, Sarawak, Consultant, 2018 - 2019, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Mechanistic basis of tumor evasion from cytotoxic T cells (CTL) surveillance in pancreatic cancers, Co-Investigator, 2017 - 2019, Fundamental Research Grant Scheme (FRGS), (National)
  • Metabolic role of fatty acid transporters (CD36) in endometrial cancer progression among obese and diabetic patients, Consultant, 2017 - 2019, Bantuan Kecil Penyelidikan (BKP), (National)
  • Regulation of cell motility by cancer-associated fibroblasts to induce stemness traits in endometrial cancer, Principal Investigator(PI), 2017 - 2019, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Nano-stealthing the STAT3-blocker for improved anti-metastatic activity: mechanistic and pharmacological studies, Co-Investigator, 2017 - 2019, Fundamental Research Grant Scheme (FRGS), (National)
  • Nano-stealthing the STAT3-blocker for improved anti-metastatic activity: mechanistic and pharmacological studies, Consultant, 2017 - 2020, Fundamental Research Grant Scheme (FRGS), (National)
  • Regulation Of Cell Motility By Cancer-associated Fibroblasts To Induce Stemness Traits In Endometrial Cancer, Principal Investigator(PI), 2017 - 2019, UM Grant - Frontier Research Grant, (National)
  • The role of fibroblast on microRNA regulation of epithelial to mesenchymal transition-mediated cisplatin resistance in bladder cancer, Co-Investigator, 2016 - 2019, Fundamental Research Grant Scheme (FRGS), (National)
  • Regulation of cancer cell epithelial-mesenchymal plasticity (EMP) by p53 gain-of-function mutations, Co-Investigator, 2016 - 2018, Fundamental Research Grant Scheme (FRGS), (National)
  • The Role Of Fibroblast On Microrna Regulation Of Epithelial To Mesenchymal Transition-mediated Cisplatin Resistance In Bladder Cancer, Consultant, 2016 - 2020, Fundamental Research Grant Scheme (FRGS), (National)
  • Differential pharmacological actions of medroxyprogesterone acetate on benign and cancer- associated endometrial fibroblasts, Principal Investigator(PI), 2015 - 2018, Fundamental Research Grant Scheme (FRGS), (National)
  • Death and Disability: The vulnerability of older people in Malaysia to urbanization and climate change, Co-Investigator, 2015 - 2016, International Funding, (International)
  • Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis, Co-Investigator, 2015 - 2018, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis, Consultant, 2015 - 2017, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science), (University)
  • Primary Cell Culture Models For Cancer Drug Discovery, Principal Investigator(PI), 2014 - 2017, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness), (University)
  • Obesity in Malaysian adolescent population: Prevalence, risk factors, complications and intervention, Co-Investigator, 2014 - 2014, High Impact Research (HIR), (University)
  • Building regional cells, Principal Investigator(PI), 2014 - 2016, TechnoFund, (National)
  • Primary cell culture models for cancer drug discovery, Principal Investigator(PI), 2014 - 2017, RU Operation, (National)
  • Differential Pharmacological Actions Of Medroxyprogestrone Acetate (mpa) On Benign- And Cancer-associated Endometrial Fibroblasts, Principal Investigator(PI), 2014 - 2018, Fundamental Research Grant Scheme (FRGS), (National)
  • Build Regional Cell, Principal Investigator(PI), 2014 - 2016, RU Operation, (National)
  • Role Of Cancer-associated Fibroblasts In The Progression Of Endometrial Cancer, Principal Investigator(PI), 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Role of cancer-associated fibroblasts in the progression of endometrial cancer, Principal Investigator(PI), 2013 - 2015, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Stromal fibroblasts as mediators for chemoresistance in oral carcinoma cells, Co-Investigator, 2013 - 2014, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Um's Nobel Endeavour Programme: Towards A Successful Career In Cancer Research, Principal Investigator(PI), 2013 - 2014, RU Operation, (National)
  • Towards a successful career in cancer research, Principal Investigator(PI), 2013 - 2014, RU Operation, (National)
  • Molecular determinants underlying the progression of normal endometrium to endometriosis, endometrial cancer and ovarian cancer, Principal Investigator(PI), 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Stromal fibroblasts as mediators of chemoresistance in oral carcinoma cells, Co-Investigator, 2012 - 2013, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Stromal Fibroblasts As Mediators Of Chemoresistance In Oral Carcinoma Cells, Consultant, 2012 - 2015, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness), (University)
  • Molecular determinants underlying the progression of normal endometrium to endometriosis, endometrial cancer and ovarian cancer, Principal Investigator(PI), 2011 - 2012, Geran Penyelidikan Universiti Malaya (UMRG), (National)
  • Targeting tumor-stellate cells interaction for novel therapeutics in pancreatic cancer, Principal Investigator(PI), 2011 - 2013, High Impact Research (HIR), (National)

CONSULTATION PROJECT/CONSULTANCY
(Project title), (Role), (From)-(Until), (Organisation).


  • Evaluator for UMRG, 2014-2014, University of Malaya
  • Evaluator for ScienceFund, 2014-2014, University of Malaya
  • Examiner for PhD candidate - Oh Li Xian, 2014-2014, University of Malaya
  • Speaker for Orthopaedic Research Symposium at Malaysian Orthopaedic Association Scientific Meeting, 2014-2014, Malaysian Orthopaedic Association
  • Examiner for PhD candidate - Sharmila Velapasamy, 2014-2014, University of Malaya
  • Judge panel for Malaysian Orthopaediac Association Scientific Meeting, 2014-2014, Malaysian Orthopaediac Association
  • Evaluator for FRGS, 2014-2014, University of Malaya
  • Examiner for MSc thesis - Tay Liang Xian, 2013-2013, Faculty of Medicine, University of Malaya
  • Facilitator, Editing Your Manuscript for Publication: Workshop for Postgraduate Students, 2012-2012, Faculty of Medicine, University of Malaya
  • Sub-Editor for The Journal of University of Malaya Medical Center, 2012-2012, The Journal of University of Malaya Medical Center
  • Judge Panel, 2012-2012, Malaysian Society for Molecular Biology and Biotechnology
  • Examiner for PhD candidate Candidature Defense, 2011-2011, Department of Pharmacology, Faculty of Medicine, University of Malaya
  • Lead Scientist, Cancer Cell Culture Facility-UMCRI, 2011-2011, University of Malaya Cancer Research Institute

AWARDS AND RECOGNITIONS
(Name of Award), (Awarding Institution), (Year Awarded), (Level).


  • Ceo@Faculty 2.0 “Coached by The Pro” Program Fellow, Ministry of Higher Education, 2017, (Government)
  • 14th Asia-Pacific Oncologists Annual Meeting, Melbourne, Australia Organizing Committee , Journal of Cancer Science & Therapy, 2017, (International)
  • University of Malaya Excellent Lecturer Award, University of Malaya, 2017, (University)
  • Organizing Committee for 13th Asia-Pacific Oncologists Annual Meeting, Editors of Journal of Cancer Science & Therapy, 2016, (International)
  • Certificate of Excellent Service, University Malaya, 2015, (University)
  • The Young Einstein Decade Y2k7 Award, Roswell Park Cancer Institute, 2007, (University)

PRESENTATIONS
(Title), (Event), (Date Presented), (Organiser), (Level).


INVITED SPEAKER
  • Targeting the fibroblasts in the microenvironment of endometrial cancer, 24th National Scientific Conference, Malaysian Institute of Medical Laboratory Sciences, 2013-09-03 to 2013-09-05, Malaysian Institute of Medical Laboratory Sciences, (National)
  • Chemoresistance in Osteosarcoma, 44th Malayasian Orthopaedic Association Annual Scientific Meeting, 2014-05-29 to 2014-06-01, (International)
  • Advanced Prostate Cancer: Journey to Resistance , 1st Ova-Pros Standalone Meeting, 2015-06-06 to 2015-06-06, Johnson&Johnson, (National)
  • Interleukin-6 secreted by cancer-associated fibroblasts induces endometrial cancer growht, 13th Asia-Pacific Oncologists Annual Meeting, 2016-10-17 to 2016-10-19, Conference Series LLC, (International)
  • Fibroblasts and their enigmatic roles in endometrial cancer progression, Visit to Institute of Advanced Biosciences, University of Grenoble Alps, 2016-12-09 to 2016-12-09, University of Grenoble Alps, (International)
  • Effects of medroxyprogesterone acetate (MPA) in activating progesterone receptor signaling in benign and cancer-associated fibroblasts of the endometrium , 14th Asia-Pacific Oncologists Annual Meeting , 2017-11-20 to 2017-11-22, Journal of Cancer Science & Therapy, (International)
POSTER
  • Cancer-associated fibroblasts promote endometrial cancer cell proliferation in vitro and in vivo, American Association for Cancer Research Annual Meeting 2014, 2014-04-05 to 2014-04-09, (International)
  • Cancer-associated fibroblasts induce c-myc expression in endometrial cancer through interleukin-6 signaling, Cell-VIB Conference: Hallmarks of Cancer, 2016-12-11 to 2016-12-13, Cell Press, (International)
EVENT ORGANISER
  • Recent Updates in Cancer Research and Drug Discovery, Pharmacology & Physiology International Scientific Congress 2014, 2014-08-22 to 2014-08-24
  • University of Malaya-Longwood Medical International Foundation Short Course on Translational Medicine, University of Malaya-Longwood Medical International Foundation Short Course on Translational Medicine, 2014-12-08 to 2014-12-12, (National)
  • Harnessing tumor-stroma interaction for cancer drug discovery, FOM Research Week 2015, 2015-05-11 to 2015-05-15, Departments of Pharmacology and Pharmacy, (University)
  • Bone Metastasis: A Priming Role by Tumor Stroma, 45th Malaysian Orthopaedic Association Annual Scientific Meeting, 2015-05-22 to 2015-05-24, Malaysian Orthopaedic Association, (National)
OTHERS
  • Mahmood Merican Award , 44th Malaysian Orthopaedic Association Annual Scientific Meeting , 2014-05-29 to 2014-06-01, (International)

EXPERT LINKAGES
(Linkages Description), (Organisation), (Year of Involvement), (Duration), (Level).


  • Malaysian Code of Responsible Conduct in Research, Prime Minister Office, 2018, 1, (National)
  • Precision Medicine Symposium, Institute Kanser Negara & Novartis Malaysia Sdn Bhd, 2017, 1, (National)
  • Speaker & mentor, 11th National Gathering of Pharmacy Students (NoGAPS) Educational Workshop, National Gathering of Pharmacy Students (NoGAPS), 2016, 1, (National)
  • Chair, Pharmacology & Physiology International Scientific Congress, 2014, 6, (International)
  • Exco member, Malaysian Society of Pharmacology & Physiology, 2014, 12, (National)
  • Public Private Research Network, Cell Tissue Technology Sdn Bhd, 2014, 1, (National)
  • Judge, 44th Malaysian Orthopaedic Association Annual Scientific Meeting, 2014, 1, (National)
  • The Schoolwide Enrichment Model Pogram, MRSM Tun Ghafar Baba, 2012, 3, (National)
  • 19th Scientific Meeting Postgraduate Oral Presentation Competition, Malaysian Society for Molecular Biology and Biotechnology, 2012, 1, (National)

EXPERT/TECHNICAL CONTRIBUTIONS
(Activity), (Organisation), (Role), (From)-(Until), (Level).


  • Mycofluor mycoplasma screening test, University of Malaya, Expert Advisor, 2018-2018, (National)
  • Industry-Academia Dialogue with YB Dato' Seri Haji Idris Jusoh, Ministry of Higher Education, Committee Member, 2018-2018, (National)
  • UM-Academia Sinica Research Symposium, University of Malaya and Academia Sinica, Committee Member, 2017-2017, (International)
  • Organizing Committee, 14th Asia Pacific Oncologist Annual Meeting, Asia Pacific Oncologist Annual Meeting, Committee Member, 2017-2017, (International)
  • Symposium on Sustainable Development, University of Malaya, Committee Member, 2017-2017, (National)
  • Cell culture hands-on training, University of Malaya, Expert Advisor, 2016-2018, (National)
  • 13th Asia Pacific Oncologist Annual Meeting, Asia Pacific Oncologist Annual Meeting, Committee Member, 2016-2016, (International)
  • Faculty of Medicine Research Week, University of Malaya, Committee Member, 2015-2015, (University)
  • University of Malaya Research Carnival, University of Malaya, Committee Member, 2015-2015, (National)
  • 45th Malaysian Orthopaedic Association Annual Scientific Meeting, Malaysian Orthopaedic Association, Committee Member, 2015-2015, (National)
  • Science Workshops for Kazakhstan Students, Science Bridge Academia, Project Leader, 2014-2014, (International)
  • Scientific writing seminar, University of Malaya, Resource Person, 2014-2014, (National)
  • Short Course on Translational Medicine, UM and Longwoord Medical International Foundation, Committee Member, 2014-2014, (International)
  • Editor, Journal of Health and Translational Medicine, Editorial Board, 2013-2018, (National)
  • Editing your manuscript for publication workshop for postgraduate students, University of Malaya, Resource Person, 2012-2012, (University)
  • Cancer Cell Culture Facility, UM Cancer Research Institute, Expert Advisor, 2011-2014, (University)

EVALUATION ACTIVITIES
(Description), (Evaluation Activity),(Year).


  • Italian Ministry of Health Research Grants, Project ,  (2018 - 2018)
  • Faculty of Medicine Research Grants, Project ,  (2018 - 2018)
  • UM Living Lab Program, Project ,  (2018 - 2018)
  • PhD thesis - Ganesh P Vythilingam, Thesis ,  (2018 - 2018)
  • Candidature defense - PhD (Nur Musfirah Binti Mahmud), Project ,  (2018 - 2018)
  • Dato' Merican Research Grant Award, Project ,  (2018 - 2018)
  • Taylor's University Conference Papers, Project ,  (2017 - 2017)
  • UM Research Grants, Project ,  (2017 - 2017)
  • UMRG, Frontier Research Cluster, Project ,  (2017 - 2017)
  • BKP grants, Project ,  (2016 - 2016)
  • PhD conversion - Hak Savatey, Project ,  (2016 - 2016)
  • PhD conversion - Khor Eng Soon, Project ,  (2016 - 2016)
  • PhD thesis - Sahya Narayanan Patmanathan, Thesis ,  (2016 - 2016)
  • LRGS Grants, Ministry of Higher Education, Project ,  (2016 - 2016)
  • Italian Ministry of Health Research Grants, Project ,  (2016 - 2016)
  • Fundamental Research Grant, MOE, Project ,  (2016 - 2016)
  • Taylor's University Research Grant, Project ,  (2015 - 2015)
  • Candidature defense (PhD) - Sathya Patmanathan, Project ,  (2015 - 2015)
  • Sciencefund, Ministry of Science, Technology & Innovation, Project ,  (2015 - 2015)
  • FRGS grants 2015, Project ,  (2015 - 2015)
  • PhD thesis - Tan Boon Shing (IMU), Thesis ,  (2014 - 2014)
  • PhD proposal - Sharmila A/P Velapasamy, Project ,  (2014 - 2014)
  • Master of Medical Science - Soo Sian Siu, Thesis ,  (2014 - 2014)
  • PhD proposal - Lai Sook Ling, Project ,  (2014 - 2014)
  • UM Research Grant projects for Frontier Science Research Cluster, Project ,  (2014 - 2014)
  • Candidature defense (PhD) - Lim Siang Hui, Project ,  (2014 - 2014)
  • Proposal seminar - Oh Li Xian, Project ,  (2014 - 2014)
  • Candidature defense (PhD) - Chong Pan Pan, Project ,  (2013 - 2013)
  • Candidature defense (MSc) - Tay Liang Xin, Project ,  (2013 - 2013)
  • Master of Medical Science - Tay Liang Xin, Thesis ,  (2013 - 2013)
  • Master of Medical Science - Wee Ai Tze, Thesis ,  (2013 - 2013)
  • Candidature defense (MSc) - Krishnamurity Ganesan, Project ,  (2013 - 2013)
  • Candidature defense (MSc) - Wee Ai Sze, Project ,  (2013 - 2013)
  • Grant reviewer, National Science Center Poland, Project ,  (2013 - 2013)
  • Italian Ministry of Health Research Grants, Project ,  (2013 - 2013)

CONTRIBUTION TO SOCIETY
(Contribution To Society), (Level), (Start Date), (End Date).


  • Moderator, Academia-Industry Forum, UM Research Carnival , (National), 16/11/2018 until 16/11/2018
  • Panelist, 6th ASEAN Future Leaders Summit (AFLES), (International), 27/07/2018 until 27/07/2018
  • Organizing Commitee, 14th Asia-Pacific Oncologists Annual Meeting, (International), 20/11/2017 until 22/11/2017
  • Volunteer for Konvensyen Komuniti SIhat Pembina Negara (KOSPEN) Peringkat Kebangsaan 2017, (Country), 19/09/2017 until 20/09/2017
  • Expert Panel for Italian Ministry of Health Research Grant, (International), 14/11/2016 until 31/03/2017
  • Organizing Committee, 13th Asia-Pacific Oncologists Annual Meeting, (International), 17/10/2016 until 19/10/2016
  • Speaker for 11th National Gathering of Pharmacy Students (NoGAPS) Education Workshop, (National), 19/08/2016 until 21/08/2016
  • Science Workshop for Kazakhstan students (Scientific Outreach Program), (International), 16/12/2014 until 24/12/2014
  • Demand-driven Innovation Project by Public-Private Research Network, (National), 18/11/2014 until 18/11/2014
  • Project Advisor, Schoolwide Enrichment Model, MRSM Tun Ghafar Baba, (Community), 09/08/2012 until 01/03/2013
  • Rapporteur for National Congress of Professor, (National), 05/07/2011 until 08/07/2011

SUPERVISION


POST GRADUATE STUDENT
(Name of Degree), (Name of Candidates), (Title of Thesis), (Academic Session)

Ongoing
  • Master Degree, Kwa Yee Chu, IMPROVING THE ANTI-METASTATIC CANCER EFFICACY OF THE STAT3 PROTEIN DIMERISATION BLOCKERS THROUGH THE USE OF MICELLAR NANO-DRUG-CARRIERS, 2018/2019
  • Doctoral Degree (phd), Geetha Nalairndran, Identification of New Molecular Targets in Androgen-Independent Prostate Cancer Using High-Throughput Kinase shRNA Library Screen., 2018/2019
  • Doctoral Degree (phd), Yogaambikai Paramanantham, -, 2018/2019
  • Master Degree, Yap Chee Voon, The role of Cancer-associated Fibroblasts in Endometrial Cancer Cells Matility and Contractility, 2018/2019
  • Master Degree, Wan Muhammad Farhan Syafiq Bin Wan Mohd Nor, Investigating the Role of miR-548m in Epithelial-mesenchymal Transition of Cancer Metastasis, 2018/2019
  • Doctoral Degree (phd), Intan Sofia Omar, Differential Effects of Progesterone Receptor Signaling in benign-and Cancer-Associated Fibroblasts of the Endometrium., 2018/2019

Completed
  • Doctoral Degree (phd), Lai Sook Ling, THE ROLE OF COLLAGEN-DISCOIDIN DOMAIN RECEPTOR 1 IN HPV-POSITIVE AND -NEGATIVE HEAD AND NECK CANCER, 2017/2018
  • Doctoral Degree (phd), Vicit Rizal A/l Eh Suk, MIXED OLEIC ACID STEALTH LIPOSOMES FOR ANTICANCER DRUG DELIVERY, 2016/2017
  • Doctoral Degree (phd), Amin Oroji, MATHEMATICAL MODELING OF THE TUMOR CELLS POPULATION DYNAMICS IN BREAST CANCER, 2016/2017
  • Doctoral Degree (phd), Wu Yuan Seng, Pancreatic Stellate Cell Secretion and Interleukin-6 Regulate Pancreatic Cancer Cell Proliferation and Epithelial-mesenchymal Transition Through Nuclear Factor Erythroid-2., 2016/2017
  • Doctoral Degree (phd), Kavita A/p S.subramaniam, ONCOGENIC ROLE OF CANCER-ASSOCIATED FIBROBLAST SECRETION IN ENDOMETRIAL CANCER PROGRESSION IN VITRO AND IN VIVO., 2015/2016
  • Doctoral Degree (phd), Varatharajan Rajavel, Dose- And Time Dependent Effects Of Oil-Palm (Elaeis Guineensis) Leaf Extract in Streptozotocin-Induced Oxidative Stress And Renal Damage In Diabetic Rats., 2014/2015

TEACHING
(Course Title), (Academic Session), (No of Student), (No of Contact Hours).


POST GRADUATE
  • Postgraduate, (1), 195, 1
  • Postgraduate, 2018/2019(2), 198, 1
  • Postgraduate, 2016/2017(2), 191, 1
  • Postgraduate, 2015/2016(1), 197, 1
  • Postgraduate , 2014/2015(1), 198, 1
FIRST DEGREE
  • ADVANCES IN MEDICAL PHARMACOLOGY, (2), 4, 6
  • PHARMACOLOGY IN NURSING, (2), 8, 3
  • PHARMACOLOGY, 2018/2019(1), 52, 7
  • PHARMACOLOGY, 2018/2019(2), 52, 3
  • Stage 2, 2018/2019(2), 151, 16
  • PHARMACOLOGY IN NURSING, 2018/2019(2), 24, 7
  • ANAESTHESIA AND PHARMACOTHERAPY FOR NEUROLOGICAL DISORDERS, 2018/2019(1), 60, 7
  • ADVANCES IN MEDICAL PHARMACOLOGY, 2018/2019(2), 5, 6
  • PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2018/2019(1), 43, 6
  • PHARMACOLOGY, 2017/2018(2), 49, 2
  • Stage 2, 2017/2018(2), 129, 16
  • PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2016/2017(1), 44, 7
  • PHARMACOLOGY, 2016/2017(2), 53, 7
  • PHARMACOLOGY, 2016/2017(1), 53, 2
  • BASIC MEDICAL SCIENCE IV, 2016/2017(2), 14, 4
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2015/2016(1), 70, 8
  • Stage 2, 2015/2016(2), 12, 8
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2015/2016(1), 15, 6
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2015/2016(2), 73, 8
  • FARMAKOLOGI, 2015/2016(1), 56, 6
  • Stage 2, 2015/2016(1), 12, 10
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2015/2016(1), 34, 9
  • DNA CLONING TECHNIQUES, 2015/2016(2), 5, 3
  • FARMAKOLOGI, 2015/2016(2), 56, 1
  • Phase 3, 2015/2016(1), 201, 1
  • BASIC MEDICAL SCIENCE IV, 2015/2016(2), 16, 6
  • BASIC MEDICAL SCIENCE IV, 2014/2015(2), 8, 6
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2014/2015(1), 68, 12
  • ADVANCED MEDICAL PHARMACOLOGY, 2014/2015(2), 5, 3
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2014/2015(1), 16, 6
  • Phase 3, 2014/2015(1), 201, 1
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2014/2015(1), 36, 9
  • FARMAKOLOGI, 2014/2015(2), 21, 1
  • FARMAKOLOGI, 2014/2015(1), 48, 13
  • Phase 2 Pharmacology, 2014/2015(1), 204, 24
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2014/2015(2), 58, 8
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2013/2014(2), 50, 10
  • BASIC MEDICAL SCIENCE IV, 2013/2014(2), 10, 4
  • FARMAKOLOGI, 2013/2014(2), 72, 4
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2013/2014(2), 10, 2
  • FARMAKOLOGI, 2013/2014(1), 72, 10
  • Phase 2 Pharmacology, 2013/2014(1), 198, 22
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2013/2014(1), 35, 5
  • Pharmacology, 2013/2014(2), 20, 14
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2012/2013(1), 54, 9
  • Phase 3b Pharmacology, 2012/2013(1), 200, 1
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2012/2013(2), 81, 6
  • FARMAKOLOGI, 2012/2013(2), 60, 6
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2012/2013(2), 24, 8
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2012/2013(1), 19, 3
  • Phase 2 Pharmacology, 2012/2013(1), 20, 17
  • FARMAKOLOGI, 2012/2013(1), 60, 11
  • Pharmacology MBBS Phase 2, 2012/2013(2), 201, 20
  • CENTRAL NERVOUS SYSTEM & THERAPY, 2011/2012(1), 19, 6
  • Phase 2 Pharmacology, 2011/2012(1), 44, 9
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2011/2012(1), 54, 1
  • Phase 2 Pharmacology, 2011/2012(2), 11, 4
  • Phase 2 Pharmacology, 2011/2012(2), 217, 2
  • Phase 2 Pharmacology, 2011/2012(1), 11, 8
  • Phase 2 Pharmacology, 2011/2012(2), 44, 6
  • PHARMACOLOGY AND HANDLING OF MEDICATION, 2011/2012(2), 25, 3
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2011/2012(2), 68, 2
  • FARMAKOLOGI, 2011/2012(2), 78, 4
  • FARMAKOLOGI, 2011/2012(1), 19, 9
  • FARMAKOLOGI, 2011/2012(2), 37, 2
  • GENERAL PRINCIPLES IN PHARMACOLOGY AND TOXICOLOGY, 2011/2012(1), 27, 3
  • FARMAKOLOGI, 2011/2012(1), 37, 2
  • PRINCIPLES OF DRUG ACTION & PERIPHERAL NERVOUS SYSTEM, 2011/2012(2), 19, 3